United States-based Rubius Therapeutics has named Spencer Fisk as its new senior vice president of manufacturing, it was reported yesterday.

The new senior vice president was Novartis' former vice president and global head of cell and gene technical development and manufacturing. He has also held a series of leadership positions for both Merck and Schering Plough.

Torben Straight Nissen, president of Rubius Therapeutics, said, 'Spencer's expertise and decades of experience in process development and manufacturing will be invaluable and I look forward to working closely together as we continue to deliver on the promise of the next generation of cellular therapies for patients in need.'